Cart
sales@molnova.com
HIV-1 Integrase Inhibitor 1
CAS No. 2146094-22-4
HIV-1 Integrase Inhibitor 1 ( —— )
Catalog No. M13429 CAS No. 2146094-22-4
A novel compound that disrupts the HIV-1 integrase LEDGF interaction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHIV-1 Integrase Inhibitor 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel compound that disrupts the HIV-1 integrase LEDGF interaction.
-
DescriptionA novel compound that disrupts the HIV-1 integrase LEDGF interaction; produces an ALLINI-like phenotype through engagement of IN sites distinct from the LEDGF pocket.
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2146094-22-4
-
Formula Weight480.58
-
Molecular FormulaC26H28N2O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(C)NS(=O)(=O)C1=CC=CC=C1C2=CC(=CC=C2)C(=O)NC3=CC=C(C=C3)CCC(=O)O
-
Chemical Name3-(4-(2'-(N-(tert-butyl)sulfamoyl)-[1,1'-biphenyl]-3-carboxamido)phenyl)propanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Burlein C, et al. ACS Chem Biol. 2017 Nov 17;12(11):2858-2865.
molnova catalog
related products
-
GSK-8999
GSK-8999 (GSK-2578999) is a novel, potent HIV-1 maturation inhibitor.
-
Deoxyrhapontin
Desoxyrhaponticin and rhaponticin could be considered as promising fatty acid synthase(FAS) inhibitors, they could inhibit intracellular FAS activity and downregulate FAS expression in human breast cancer MCF-7 cells.
-
BMS-986001
A thymidine analogue nucleoside reverse transcriptase inhibitor (NRTI) that inhibits HIV-2 isolates from treatment-naive individuals with EC50 of 30-81 nM.
